FireEye Vision Completes Nearly RMB 10 Million Angel Funding to Accelerate Digital Vision Training Platform for Children and Adolescents

VCBeat learned exclusively that,深耕数字视光领域的Shenzhen Huoyanjing Medical Technology Co., Ltd. (referred to as "Huoyanjing")Announced the completion byShenzhen Timesbole Venture Capital Investment Management Co., Ltd.Exclusive Investment of Nearly RMB 10 Million in Angel Round Financing. This round of financing will accelerate the R&D iteration and market expansion of Huo Yan Jing Jing in the XR intelligent medical field of optometry, promoting myopia prevention and control technology for children and adolescents into a new stage of intelligence.

Fire Eye Crystal was established in 2022, dedicated to building a digital optometry platform using XR+AI technology to address the imbalance in medical resources and bring benefits to more patients with eye health issues. Current products include the Fire Eye Crystal Youth VR Intelligent Vision Training Device M1, Adult Vision Fatigue and Presbyopia Intelligent Vision Training Device, and the Shilang Qing VR Low Vision Intelligent Visual Aid.

The myopia rate among children and adolescents in China has remained persistently high. The three major trends in myopia among Chinese children and adolescents are: younger age of onset, faster progression of myopia, and an increasing proportion of children with high myopia.

The recent "Report on the Prevention and Control of Myopia in Children and Adolescents in the Information Age" shows that the prevalence of myopia among children and adolescents in China has exceeded 60%, and in the future, there will be at least 960 million people with myopia in China. The occurrence and harm of myopia are irreversible, and high myopia can lead to blindness-causing eye diseases such as cataracts, retinal detachment, macular hemorrhage, and glaucoma. For children and adolescents, myopia is not as simple as "wearing a pair of glasses." Therefore, the prevention and control of myopia are particularly important.

Currently, effective means for myopia prevention and control in children and adolescents include low-concentration atropine, orthokeratology lenses (OK lenses), and multi-functional defocus lenses, among others. While these methods have shown some effectiveness, they each come with certain limitations. For instance, atropine can easily cause photophobia and is only suitable for accommodative myopia; OK lenses are applicable to individuals aged 8 years or older with myopia of over 200 degrees, but the fitting process is complicated and carries a risk of infection. Defocus lenses are expensive, have an adaptation period that occurs in stages, and require long-term replacement. Traditional physical training relies on manual supervision, making it difficult to ensure professionalism and patient compliance. Moreover, the high cost of intervention (e.g., annual expenses for OK lenses exceed ten thousand yuan) discourages many families.

The myopia conditions and coping methods of children and adolescents vary among individuals, making the proposal of personalized and novel solutions crucial. The intelligence of optometry has become a key approach to addressing this issue.

The core product of the company, the Fire Eye Crystal VR Intelligent Vision Training Instrument M1 for teenagers and children, is an intelligent visual health solution jointly developed by Fire Eye Crystal and Zhongshan Ophthalmology. Relying on an integrated technology platform of "optics, mechanics, electronics, software, and computing," it provides myopia prevention, myopia control, and visual function examination services for children and adolescents aged 6-12.

This product adopts the globally leading Pancake short-focus optical technology, creating the thinnest and lightest near-eye ultra-distance product in the industry (with a total weight of only 160 grams). It is comfortable and easy to wear, meeting national-level visual health safety standards and TUV anti-blue light certification, ensuring the safety of non-invasive training. In addition, the product can design differentiated training programs based on the visual developmental characteristics of children at different ages and individual visual function parameters. The accompanying optometry cloud system establishes exclusive vision records for children, documenting professional optometric data such as diopter, axial length, PRA/NRA, and generates personalized training plans through big data analysis in the cloud, delivering precise myopia prevention and control solutions that meet clinical standards. From the healthcare-grade products Fire Eye Jingjing E1 and E1Pro to the successful launch of the medical-grade product M1, the company has consistently upheld an innovative spirit, driving continuous iteration and upgrading of its products.

At the technical level, Huoyanjingjing innovatively integrates the "peripheral defocus theory" with "infinite zoom technology," dynamically simulating the effects of peripheral defocus lenses through image simulation technology and achieving seamless zoom adjustment from 0.10 meters to infinity. This significantly enhances myopia prevention and control effects—according to Phase II clinical research conducted by Zhongshan Ophthalmology, after a single training session, intraocular pressure decreased, choroidal blood flow density increased, and 90% of participants showed improved visual function after one month, with unaided vision enhanced. Over a six-month observation period, the progression of refractive error slowed by over 60%, and axial length growth was reduced by nearly 50%. Its comprehensive myopia control capability is equivalent to or surpasses that of traditional orthokeratology lenses (OK lenses) and defocus lenses, while reducing intervention costs to 1/5 to 1/10 of traditional methods, greatly alleviating the financial burden on families.

At the same time, the product innovatively combines the "TOP" (visual function, defocus, and distance viewing) triple-effect fusion training mode, integrating a closed-loop feedback mechanism and AI-customized content, increasing training compliance by over 40% and solving the pain point of "difficulty in persistence" associated with traditional methods.

At the same time, Huoyanjingjing has built a digital vision training platform that integrates "testing, training, entertainment, and service." The system incorporates vision training into interactive and fun scenarios, stimulating children's active participation through gamified design. While alleviating visual fatigue, it enhances the eye muscle’s regulatory ability and increases choroidal blood flow, thereby achieving the purpose of myopia prevention and control.

In addition, the platform deeply integrates with clinical needs, achieving full-chain digital migration from screening, intervention to tracking. This makes doctors "dare to use" it, service providers find it "easy to use," parents "want to use" it, and children "love to use" it, truly promoting myopia prevention and control to shift from "passive treatment" to "active prevention," and "bringing professional optometry services home."

It is reported that Huoyanjingjing ("Fire Eye Crystal") takes "hospitals + tertiary industry" as its core channel, rapidly penetrating the market through the H2C (Hospital to Consumer) model while gradually expanding into large chain optometry centers and online scenarios. The company has already launched clinical research projects with several public Class III Grade A specialized hospitals in cities such as Guangzhou, Shanghai, Chongqing, and Hunan, partnered with private listed ophthalmology institutions, and collaborated with over 20 optometry centers. It is also actively developing an AI optometry consultant intelligent agent, covering professional services such as patient inquiries, optometry prescription interpretations, and recommendations and evaluations of prevention and control solutions.

In the future, Huoyanjingjing will cooperate with more experts to quickly carry out paradigm development, clinical verification, and market promotion for amblyopia, adult visual fatigue, and presbyopia, jointly advancing the transformation from clinical theory to product realization.

Regarding the acquisition of this round of financing, Chen Wei, founder of Huoyanjingjing, stated: The metaverse and digital healthcare have gone through the concept phase, exploration phase, and model validation phase over the past few years. Currently, it has officially entered the first year of AI + healthcare. Due to the vast market potential in the optometry field, the essential need for eye health among the population, the limitations of traditional diagnostic methods, and the inherent contradiction of inaccessible primary healthcare resources, achieving full-cycle management of national eye health must rely on digital and intelligent solutions.

We believe that intelligent vision training, as a new type of non-invasive, portable, efficient, inclusive, and well-experienced treatment model, will achieve seamless intelligent migration throughout the entire vision training service process with the continuous support of XR optical technology, AI large models, and other technologies. This will become a major innovative trend for medical institutions to increase revenue and efficiency, liberate doctors, and benefit patients.

Thank you to Timesbole and Longgang Mother Fund for recognizing our team and products. Fire Eyes Crystal will continue to deepen its expertise in the intelligent vision training field,打通 clinical needs, optometric theory, patents to product transformation, and business model coverage. Through medical-engineering integration projects with top hospitals and experts in the industry such as Tongren and Zhongshan Ophthalmology, collaboration on standard setting and technology integration with the industrial chain, and deepened innovation with industry partners, we will focus on clinical needs and precision medicine standards to provide an integrated "measurement-training-service-entertainment" product. We will continuously enrich our pipeline and expand the service population (myopia prevention and control for teenagers and children, visual fatigue and early presbyopia for adults, assisted reading and entertainment for low-vision groups), striving to become a leader in the new generation of intelligent vision training.

Liu Xiayue, Senior Vice President of Shenzhen Timesbole Venture Capital Investment Management Co., Ltd., stated: As the angel round investor of Huoyanjingjing, Timesbole highly values the long-term potential of the intelligent optometry track. The demand for myopia prevention and control among children and adolescents in China is rigid, with a market potential exceeding 100 billion yuan. Traditional methods face challenges such as low compliance and high costs, making intelligent solutions the key to breaking through industry barriers. By leveraging XR+AI technology, the Huoyanjingjing team has achieved clinical-grade myopia prevention and control. Their unique TOP triple-effect training model reduces intervention costs to one-fifth of traditional methods, with clinical data showing better axial length control than orthokeratology lenses (OK lenses). We look forward to the company continuing to lead the intelligent transformation of optometry services, making innovative technologies accessible to a broader population. Meanwhile, Timesbole will continue to provide in-depth support through industrial chain resource integration and market expansion, helping the company become a benchmark in the digital therapeutics field and jointly promoting the development of national eye health initiatives.

Shenzhen Timesbole Venture Capital Investment Management Co., Ltd., established in April 2011 in Shenzhen, has accumulated assets under management exceeding 240 billion yuan through the company and its affiliates. Positioned as an expert in industrial investment, the company is committed to providing in-depth industrial investment services and possesses core competitiveness in areas such as industrial investment promotion, market capitalization enhancement for listed companies, and management empowerment. With a prudent investment style and outstanding performance, Timesbole has become one of China's leading industrial chain investment institutions. The company has long focused on the carbon neutrality, next-generation smart devices, biomedicine, and foundational technology industrial chains. Dozens of its invested enterprises have achieved IPO listings, demonstrating consistent performance. In rankings by authoritative rating agencies such as Zero2IPO, ChinaVenture, and the Private Equity Fund Research Center, Timesbole consistently ranks among the top in China.